Skip to main content

Table 3 Three- and 5-year survival probabilities depending on the parameters significant in the univariate analysis

From: The assessment of risk factors for long-term survival outcome in ypN0 patients with rectal cancer after neoadjuvant therapy and radical anterior resection

 

DFS

DSS

OS

 

3 years%

5 years%

3 years%

5 years%

3 years%

5 years%

Total study group

89.0

85.7

97.9

93.4

91.3

84.8

No AL

90.8

88.9

99.3

95.3

93.7

88.4

AL

80.9

71.2

91.5

84.3

81.1

68.6

Early AL

88.8

81.4

95.2

89.3

81.8

72.2

Late AL

70.7

56.6

85.7

77.9

80.0

63.6

CCI ≤ 3

90.2

87.4

98.3

94.7

92.4

86.0

CCI > 3

67.5

56.2

80.0

70.0

72.7

63.6

  1. DFS disease-free survival, DSS disease-specific survival, OS overall survival, AL anastomotic leakage, CCI Charlson comorbidity index